GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | November 21, 2024 |
PDB ID | UniProt ID | Title ▼ | Descriptor |
---|---|---|---|
1FS4 | P00489 | Structures of glycogen phosphorylase-inhibitor complexes and the implications for structure-based drug design | GLYCOGEN PHOSPHORYLASE (E.C.2.4.1.1) |
1GGN | P00489 | Structures of glycogen phosphorylase-inhibitor complexes and the implications for structure-based drug design | |
7VPP | K7GMF9 | Structures of a deltacoronavirus spike protein bound to porcine and human receptors indicate the risk of virus adaptation to humans | |
7VPP | A0A4P8D758 | Structures of a deltacoronavirus spike protein bound to porcine and human receptors indicate the risk of virus adaptation to humans | |
7VPQ | P15144 | Structures of a deltacoronavirus spike protein bound to porcine and human receptors indicate the risk of virus adaptation to humans | |
7VPQ | A0A4P8D758 | Structures of a deltacoronavirus spike protein bound to porcine and human receptors indicate the risk of virus adaptation to humans | |
8CXI | A0A142DS37 | Structures of Zika Virus in Complex with Antibodies Targeting E Dimer Epitopes and Basis for Neutralization Efficacy | |
8CXI | Q9H9E1 | Structures of Zika Virus in Complex with Antibodies Targeting E Dimer Epitopes and Basis for Neutralization Efficacy | |
8CXI | A0A1S6LXE0 | Structures of Zika Virus in Complex with Antibodies Targeting E Dimer Epitopes and Basis for Neutralization Efficacy | |
8CXI | 8CXI | Structures of Zika Virus in Complex with Antibodies Targeting E Dimer Epitopes and Basis for Neutralization Efficacy | |
4OKR | O00816 | Structures of Toxoplasma gondii MIC2 | Micronemal protein MIC2 |
7S0Z | M4NKV9 | Structures of TcdB in complex with R-Ras | |
7S0Z | P10301 | Structures of TcdB in complex with R-Ras | |
7WS0 | P0DTC2 | Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development | |
7WS0 | 7WS0 | Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development | |
7WS1 | P0DTC2 | Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development | |
7WS1 | 7WS1 | Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development | |
7WS3 | P0DTC2 | Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development | |
7WS3 | 7WS3 | Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development | |
7WS5 | P0DTC2 | Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development | |
7WS5 | 7WS5 | Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development | |
7WS7 | P0DTC2 | Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development | |
7WS7 | 7WS7 | Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development | |
7WS8 | P0DTC2 | Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development | |
7WS8 | Q9BYF1 | Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development | |
7WS9 | P0DTC2 | Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development | |
7WS9 | Q9BYF1 | Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development | |
7WSA | P0DTC2 | Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development | |
7WSA | Q9BYF1 | Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development | |
3SO3 | Q9Y5Y6 | Structures of Fab-Protease Complexes Reveal a Highly Specific Non-Canonical Mechanism of Inhibition. | |
3SO3 | 3SO3 | Structures of Fab-Protease Complexes Reveal a Highly Specific Non-Canonical Mechanism of Inhibition. | |
3U5Y | Q9SPP9 | Structures of Alkaloid Biosynthetic Glucosidases Decode Substrate Specificity | |
2PUN | O31663 | Structures of 5-methylthioribose kinase reveal substrate specificity and unusual mode of nucleotide binding | |
1Z32 | P04745 | Structure-function relationships in human salivary alpha-amylase: Role of aromatic residues | |
7BM6 | G0LCA3 | Structure-function analysis of a new PL17 oligoalginate lyase from the marine bacterium Zobellia galactanivorans DsijT | |
3E81 | Q8A712 | Structure-function Analysis of 2-Keto-3-deoxy-D-glycero-D-galacto-nononate-9-phosphate (KDN) Phosphatase Defines a New Clad Within the Type C0 HAD Subfamily | |
2CIS | Q03161 | Structure-based functional annotation: Yeast ymr099c codes for a D- hexose-6-phosphate mutarotase. Complex with tagatose-6-phosphate | |
2CIR | Q03161 | Structure-based functional annotation: Yeast ymr099c codes for a D- hexose-6-phosphate mutarotase. Complex with glucose-6-phosphate | |
5M0D | Q64610 | Structure-based evolution of a hybrid steroid series of Autotaxin inhibitors | |
5M0E | Q64610 | Structure-based evolution of a hybrid steroid series of Autotaxin inhibitors | |
5M0M | Q64610 | Structure-based evolution of a hybrid steroid series of Autotaxin inhibitors | |
5M0S | Q64610 | Structure-based evolution of a hybrid steroid series of Autotaxin inhibitors | |
3LAQ | P06869 | Structure-based engineering of species selectivity in the uPA-uPAR interaction | Urokinase-type plasminogen activator (E.C.3.4.21.73), Urokinase plasminogen activator surface receptor |
3LAQ | P35456 | Structure-based engineering of species selectivity in the uPA-uPAR interaction | Urokinase-type plasminogen activator (E.C.3.4.21.73), Urokinase plasminogen activator surface receptor |
7SEM | 7SEM | Structure-based design of prefusion-stabilized human metapneumovirus fusion proteins | |
7SEM | H6X1Z0 | Structure-based design of prefusion-stabilized human metapneumovirus fusion proteins | |
7SEJ | H6X1Z0 | Structure-based design of prefusion-stabilized human metapneumovirus fusion proteins | |
5SXN | P00797 | Structure-based design of a new series of N-piperidin-3-ylpyrimidine-5-carboxamides as renin inhibitors | Renin (E.C.3.4.23.15) |
5SY2 | P00797 | Structure-based design of a new series of N-piperidin-3-ylpyrimidine-5-carboxamides as renin inhibitors | Renin (E.C.3.4.23.15) |
5SY3 | P00797 | Structure-based design of a new series of N-piperidin-3-ylpyrimidine-5-carboxamides as renin inhibitors | Renin (E.C.3.4.23.15) |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024